查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1836307

癌症活體組織切片市場，按產品、按類型、按應用、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Cancer Biopsy Market, By Product, By Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 388 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年癌症切片市場規模價值 322.6812 億美元，2025 年至 2032 年的複合年成長率為 8.23%。

癌症活體組織切片是一種用於診斷癌症的醫療程序，透過從身體可疑部位取出少量組織、體液或細胞樣本進行實驗室檢查。此檢查有助於確定癌症的存在、類型和分期，並指導醫生製定合適的治療方案。根據異常部位，活體組織切片可以採用不同的方法進行，例如針吸活體組織切片、手術活體組織切片或內視鏡活體組織切片。

癌症切片市場-市場動態

全球癌症盛行率不斷上升，推動市場需求

全球癌症切片市場受全球癌症盛行率急劇上升的驅動。世界衛生組織 (WHO) 的數據顯示，2022 年全球新增癌症病例近 2,000 萬例，凸顯了診斷解決方案的迫切性。各國政府和衛生機構都強調早期發現，這直接刺激了活體組織切片需求。然而，液體活體組織切片和新一代定序等先進技術仍然成本高昂，限制了中低收入國家對這些技術的使用。

在機會方面，液體活體組織切片的應用正在加速：美國食品藥物管理局 (FDA) 已批准 40 多種用於靶向癌症治療的伴隨診斷產品，確保更廣泛的臨床整合。此外，諸如美國「癌症登月計畫」和歐盟「戰勝癌症計畫」等大規模政府措施正在大幅增加對癌症研究和創新的資助。這些因素共同創造了一個市場格局：不斷上升的發病率和支持性政策超過了成本挑戰，從而確保了全球癌症治療的持續成長。

癌症切片市場-細分分析：

全球癌症活體組織切片市場根據產品、類型、應用、最終用戶和地區進行細分。

市場依產品分為三類：服務、儀器以及試劑盒、耗材。預計在預測期內，服務領域將佔據主要市場佔有率，這得益於全球範圍內對先進診斷檢測、病理學服務的需求不斷成長，以及微創活體組織切片程序的日益普及。

根據應用，市場分為十二類：乳癌、子宮頸癌、大腸癌、攝護腺癌、肺癌、血癌、皮膚癌、腎癌、卵巢癌、胰臟癌、肝癌等。其中，乳癌預計將在預測期內佔據最大的市場佔有率，這得益於其高盛行率、篩檢項目的不斷增加以及先進診斷技術的日益普及。

癌症活體組織切片市場——地理洞察

北美癌症切片市場佔據全球市場主導地位，佔有率超過40%。高發病率和強力的政策框架進一步鞏固了該地區的領先地位。根據美國癌症統計數據，2022年報告了279,731例女性乳癌新病例，癌症總發生率持續逐年上升。

新一代定序的醫保覆蓋以及FDA對液體活體組織切片檢測（例如Guardant360 CDx）的批准，進一步加速了液體活體組織切片的普及。在歐洲，歐盟抗癌計畫旨在確保2025年90%的符合資格的公民能夠接受篩檢，而英國國民醫療服務體系（NHS England）則擴大了液體活體組織切片試點項目，以提高早期診斷水平。亞太地區是成長最快的市場：印度ICMR預測2024年將新增153萬例病例，日本報告2022年將新增約101萬例病例，這兩個地區都顯著擴大了活體組織切片需求。總體而言，政策支持、報銷透明度以及病例數量的成長使北美保持領先地位，而歐洲和亞太地區則迅速縮小差距。

癌症切片市場-競爭格局：

隨著對早期精準癌症診斷的需求日益成長，各公司正致力於提升活體組織切片解決方案的創新和效率。市場參與者正致力於開發微創活體組織切片技術，整合先進的影像引導技術，並提升分子檢測能力以提高精準度。各公司正與研究機構和醫療保健機構進行策略合作，以拓展臨床應用。此外，各公司正在投資自動化、數位病理學和人工智慧診斷技術，以加速獲得結果、提高準確性並獲得競爭優勢。

目錄

第 1 章：癌症活體組織切片市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 癌症切片市場產品片段
    • 癌症活體組織切片市場片段（按類型）
    • 癌症切片市場片段（按應用）
    • 癌症活體組織切片市場片段（按最終用戶）
    • 癌症活體組織切片市場（按國家/地區）
    • 癌症活體組織切片市場（按地區）
  • 競爭洞察

第3章：癌症切片關鍵市場趨勢

  • 癌症切片市場促進因素
    • 市場促進因素的影響分析
  • 癌症切片市場限制
    • 市場限制的影響分析
  • 癌症切片市場機遇
  • 癌症切片市場未來趨勢

第4章：癌症活體組織切片產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：癌症切片市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：癌症切片市場格局

  • 2024年癌症切片市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：癌症切片市場－按產品

  • 概述
    • 按產品細分市場佔有率分析
    • 服務
    • 儀器
    • 套件和耗材

第 8 章：癌症活體組織切片市場 - 按類型

  • 概述
    • 按類型細分市場佔有率分析
    • 液體活體組織切片
      • 芯針切片（CNB）
      • 細針抽吸（FNA）
    • 組織切片
      • 手術切片
      • 針吸切片
    • 其他

第9章：癌症切片市場－按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 乳癌
    • 子宮頸癌
    • 大腸直腸癌
    • 攝護腺癌
    • 肺癌
    • 血癌
    • 皮膚癌
    • 腎癌
    • 卵巢癌
    • 胰腺癌
    • 肝癌
    • 其他

第 10 章：癌症活體組織切片市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院
    • 診斷中心
    • 癌症研究中心
    • 研究與學術

第 11 章：癌症活體組織切片市場 - 按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美癌症切片主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲癌症切片檢查主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按產品）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 亞太地區癌症切片主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品）
    • 亞太地區市場規模及預測（按類型）
    • 亞太地區市場規模及預測（按應用）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲癌症活體組織切片主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品）
    • 拉丁美洲市場規模及預測（按類型）
    • 拉丁美洲市場規模及預測（按應用）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲癌症活體組織切片主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依產品）
    • MEA 市場規模和預測（按類型）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 12 章：癌症活體組織切片產業主要供應商分析

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • QIAGEN
    • ANGLE plc
    • Illumina, Inc.
    • BD (Becton, Dickinson and Company)
    • Hologic, Inc.
    • Myriad Genetics, Inc.
    • Biocept, Inc.
    • Danaher
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd.
    • GRAIL, Inc.
    • Lucence Health Inc.
    • Guardant Health Inc.
    • Freenome Holdings, Inc.
    • Exact Sciences Corporation
    • Biodesix (Integrated Diagnostics)
    • Epigenomics AG
    • Oncimmune
    • HelioHealth (Laboratory for Advanced Medicine)
    • Chronix Biomedical, Inc.
    • Genesystems, Inc. (Genesys Biolabs)
    • Personal Genome Diagnostics Inc.
    • Personalis Inc.
    • Natera, Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5676

Cancer biopsy market size was valued at US$ 32,268.12 Million in 2024, expanding at a CAGR of 8.23% from 2025 to 2032.

A cancer biopsy is a medical procedure used to diagnose cancer by removing a small sample of tissue, fluid, or cells from a suspicious area in the body for laboratory examination. This test helps determine the presence, type, and stage of cancer, guiding doctors in creating appropriate treatment plans. Biopsies can be performed using different methods such as needle biopsy, surgical biopsy, or endoscopic biopsy, depending on the location of the abnormality.

Cancer Biopsy Market- Market Dynamics

Increasing prevalence of cancer among people globally to propel market demand

The global cancer biopsy market is driven by the sharp rise in cancer prevalence worldwide. According to the World Health Organization (WHO), nearly 20 million new cancer cases were recorded in 2022, highlighting the urgency for diagnostic solutions. Governments and health agencies are emphasizing early detection, which directly fuels biopsy demand. However, advanced techniques such as liquid biopsy and next-generation sequencing remain costly, restricting access in low- and middle-income countries.

On the opportunity side, liquid biopsy adoption is accelerating: the U.S. Food and Drug Administration (FDA) has already approved more than 40 companion diagnostics for targeted cancer therapies, ensuring wider clinical integration. Additionally, large-scale government initiatives-such as the U.S. Cancer Moonshot program and the European Union's Beating Cancer Plan-are significantly boosting funding for cancer research and innovation. These combined forces create a market landscape where rising incidence and supportive policy outweigh cost challenges, ensuring sustained global growth.

Cancer Biopsy Market- Segmentation Analysis:

The Global Cancer Biopsy Market is segmented on the basis of Product, Type, Application, End User, and Region.

The market is divided into three categories based on Product: services, instruments, and kits & consumables. The services segment is expected to hold the major market share during the forecast period, driven by rising demand for advanced diagnostic testing, pathology services, and increasing adoption of minimally invasive biopsy procedures worldwide.

The market is divided into twelve categories based on Application: breast cancer, cervical cancer, colorectal cancer, prostate cancer, lung cancer, blood cancer, skin cancer, kidney cancer, ovarian cancer, pancreatic cancer, liver cancer, and others. Among these, the breast cancer segment is expected to hold the largest market share during the forecast period, driven by its high prevalence, rising screening programs, and growing adoption of advanced diagnostic techniques

Cancer Biopsy Market- Geographical Insights

North America cancer biopsy market dominated the global market with over 40% share. The region's lead is reinforced by high incidence rates and strong policy frameworks. According to U.S. Cancer Statistics, 279,731 new female breast cancer cases were reported in 2022, and total cancer incidence continues to rise year-on-year.

Medicare coverage for next-generation sequencing and FDA approvals of liquid biopsy tests, such as Guardant360 CDx, further accelerate adoption. In Europe, the EU Beating Cancer Plan aims to ensure 90% of eligible citizens are offered screening by 2025, while NHS England has expanded liquid biopsy pilots to improve early diagnosis. Asia Pacific is the fastest-growing market: India's ICMR projects 1.53 million new cases in 2024, and Japan reported around 1.01 million new cases in 2022, both significantly expanding biopsy demand. Collectively, policy backing, reimbursement clarity, and rising case volumes sustain North America's lead while Europe and Asia Pacific rapidly close the gap.

Cancer Biopsy Market- Competitive Landscape:

Rising demand for early and accurate cancer diagnosis is driving companies to enhance innovation and efficiency in biopsy solutions. Market participants are focusing on developing minimally invasive biopsy techniques, integrating advanced imaging guidance, and improving molecular testing capabilities to increase precision. Strategic collaborations with research institutions and healthcare providers are being pursued to expand clinical applications. In addition, companies are investing in automation, digital pathology, and AI-powered diagnostics to accelerate results, strengthen accuracy, and gain a competitive advantage.

Recent Developments:

In April 2025, Labcorp launched molecular residual disease and liquid biopsy testing, offering advanced genomic insights to support personalized cancer treatment, improve disease monitoring, and aid in early relapse detection for better patient outcomes across diverse cancer types.

In June 2025, M42 announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to introduce advanced liquid biopsy testing in the UAE, enhancing cancer diagnosis, treatment decisions, and biomarker testing for improved precision oncology outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER BIOPSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • QIAGEN
  • ANGLE plc
  • Illumina, Inc.
  • BD (Becton, Dickinson and Company)
  • Hologic, Inc.
  • Myriad Genetics, Inc.
  • Biocept, Inc.
  • Danaher
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GRAIL, Inc.
  • Lucence Health Inc.
  • Guardant Health Inc.
  • Freenome Holdings, Inc.
  • Exact Sciences Corporation
  • Biodesix (Integrated Diagnostics)
  • Epigenomics AG
  • Oncimmune
  • HelioHealth (Laboratory for Advanced Medicine)
  • Chronix Biomedical, Inc.
  • Genesystems, Inc. (Genesys Biolabs)
  • Personal Genome Diagnostics Inc.
  • Personalis Inc.
  • Natera, Inc.
  • Others

GLOBAL CANCER BIOPSY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Services
  • Instruments
  • Kits & Consumables

GLOBAL CANCER BIOPSY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Liquid Biopsies
  • Core Needle Biopsy (CNB)
  • Fine Needle Aspiration (FNA)
  • Tissue Biopsies
  • Surgical Biopsies
  • Needle Biopsies
  • Others

GLOBAL CANCER BIOPSY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Lung Cancer
  • Blood Cancer
  • Skin Cancer
  • Kidney Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Liver Cancer
  • Others

GLOBAL CANCER BIOPSY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Centers
  • Cancer Research Centers
  • Research & Academics

GLOBAL CANCER BIOPSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Biopsy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Biopsy Market Snippet by Product
    • 2.1.2. Cancer Biopsy Market Snippet by Type
    • 2.1.3. Cancer Biopsy Market Snippet by Application
    • 2.1.4. Cancer Biopsy Market Snippet by End User
    • 2.1.5. Cancer Biopsy Market Snippet by Country
    • 2.1.6. Cancer Biopsy Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Biopsy Key Market Trends

  • 3.1. Cancer Biopsy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Biopsy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Biopsy Market Opportunities
  • 3.4. Cancer Biopsy Market Future Trends

4. Cancer Biopsy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Biopsy Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cancer Biopsy Market Landscape

  • 6.1. Cancer Biopsy Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Biopsy Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Services
    • 7.1.3. Instruments
    • 7.1.4. Kits & Consumables

8. Cancer Biopsy Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 8.1.2. Liquid Biopsies
      • 8.1.2.1. Core Needle Biopsy (CNB)
      • 8.1.2.2. Fine Needle Aspiration (FNA)
    • 8.1.3. Tissue Biopsies
      • 8.1.3.1. Surgical Biopsies
      • 8.1.3.2. Needle Biopsies
    • 8.1.4. Others

9. Cancer Biopsy Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Breast Cancer
    • 9.1.3. Cervical Cancer
    • 9.1.4. Colorectal Cancer
    • 9.1.5. Prostate Cancer
    • 9.1.6. Lung Cancer
    • 9.1.7. Blood Cancer
    • 9.1.8. Skin Cancer
    • 9.1.9. Kidney Cancer
    • 9.1.10. Ovarian Cancer
    • 9.1.11. Pancreatic Cancer
    • 9.1.12. Liver Cancer
    • 9.1.13. Others

10. Cancer Biopsy Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Centers
    • 10.1.4. Cancer Research Centers
    • 10.1.5. Research & Academics

11. Cancer Biopsy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cancer Biopsy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cancer Biopsy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cancer Biopsy Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Cancer Biopsy Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Cancer Biopsy Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cancer Biopsy Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. QIAGEN
    • 12.2.2. ANGLE plc
    • 12.2.3. Illumina, Inc.
    • 12.2.4. BD (Becton, Dickinson and Company)
    • 12.2.5. Hologic, Inc.
    • 12.2.6. Myriad Genetics, Inc.
    • 12.2.7. Biocept, Inc.
    • 12.2.8. Danaher
    • 12.2.9. Thermo Fisher Scientific, Inc.
    • 12.2.10. F. Hoffmann-La Roche Ltd.
    • 12.2.11. GRAIL, Inc.
    • 12.2.12. Lucence Health Inc.
    • 12.2.13. Guardant Health Inc.
    • 12.2.14. Freenome Holdings, Inc.
    • 12.2.15. Exact Sciences Corporation
    • 12.2.16. Biodesix (Integrated Diagnostics)
    • 12.2.17. Epigenomics AG
    • 12.2.18. Oncimmune
    • 12.2.19. HelioHealth (Laboratory for Advanced Medicine)
    • 12.2.20. Chronix Biomedical, Inc.
    • 12.2.21. Genesystems, Inc. (Genesys Biolabs)
    • 12.2.22. Personal Genome Diagnostics Inc.
    • 12.2.23. Personalis Inc.
    • 12.2.24. Natera, Inc.
    • 12.2.25. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us